Dengue Vaccines: The Promise and Pitfalls of Antibody-Mediated Protection-Reference-Cited by-同舟云学术

Dengue Vaccines: The Promise and Pitfalls of Antibody-Mediated Protection

Published:2021-01 Issue:1 Volume:29 Page:13-22
ISSN:1931-3128
Container-title:Cell Host & Microbe
language:en
Short-container-title:Cell Host & Microbe

Author:

Martinez David R.,Metz Stefan W.,Baric Ralph S.

Publisher

Elsevier BV

Subject

Virology,Microbiology,Parasitology

Reference88 articles.

1. T-cell activation and induction of antibodies and memory T cells by immunization with inactivated Japanese encephalitis vaccine;Aihara;Viral Immunol.,2000

2. Human CD4+ T cell responses to an attenuated tetravalent dengue vaccine parallel those induced by natural infection in magnitude, hla restriction, and antigen specificity;Angelo;J. Virol.,2017

3. Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in mice;Babu;Vaccine,2008

4. Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial;Beckett;Vaccine,2011

5. Immunization with a live attenuated dengue-2-virus candidate vaccine (16681-PDK 53): clinical, immunological and biological responses in adult volunteers;Bhamarapravati;Bull. World Health Organ.,1987

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Envelope domain III E ₃₂₄ , E ₃₅₁ , and E ₃₈₀ mutations lever adaptive evolution of DENV-1 genotype I;Journal of Virology;2024-09-04

2. Flavivirus cross-reactivity: Insights into e-protein conservancy, pre-existing immunity, and co-infection;The Microbe;2024-09

3. Whole Genome Sequencing of DENV-2 isolated fromAedes aegyptimosquitoes in Esmeraldas, Ecuador. Genomic epidemiology of genotype III Southern Asian-American in the country;2024-02-08

4. Exploring the viral protease inhibitor space driven by consensus scoring-based virtual screening;In Silico Pharmacology;2023-12-02

5. Viral Components Trafficking with(in) Extracellular Vesicles;Viruses;2023-11-28